Connect with us

International

E.U. Reg. Backs Lung Cancer Drug

EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.

Published

8 months ago

on

September 19, 2023

By

EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.

The recommendation is based on the mid-stage data that showed Enhertu showed objective response rate of 49%.

The drug is already approved in the European Union as a treatment for patients with an advanced form of breast cancer.

Related Topics:Astrazeneca Enhertu European Union Lung Cancer Our News our news Bahamas

Iran & U.S. $6B Detainee Swap

Poland: Cash For Visa Scandal Erupts

Comments

National1 day ago

Bus Drivers: What 25 Cents Could Do For Me?

National2 days ago

New Providence Resident: I Don’t Know Why It’s Taking So Long, I’m A Bahamian

Business2 days ago

RBC Royal Bank Appoints New Managing Director for The Bahamas and Turks & Caicos

courtroom

courtroom

Court3 hours ago

Suretors Ordered to Pay $30K Bail After Murder Suspect Jumps Bail

Education2 days ago

UB Students Told to Use AI Skills to Build Stronger, Resilient Bahamas

Court2 days ago

North Abaco MP’s Former Girlfriend Testifies in Rape Trial

National2 days ago

Teachers Union President: It’s Time to Start Testing Students

Court3 hours ago

Boy Accused of Killing Relative Granted $10K Bail